Filing Details
- Accession Number:
- 0000899243-22-029030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-17 17:39:29
- Reporting Period:
- 2022-08-15
- Accepted Time:
- 2022-08-17 17:39:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-15 | 6,571 | $155.57 | 67,451 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-15 | 1,254 | $300.30 | 66,197 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-15 | 4,242 | $301.61 | 61,955 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-15 | 400 | $302.55 | 61,555 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-15 | 2,339 | $303.78 | 59,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-15 | 6,990 | $304.67 | 52,226 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-15 | 6,948 | $305.38 | 45,278 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-15 | 6,571 | $0.00 | 6,571 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
- Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $300.30 (range $300.00 to $300.73).
- Open market sales reported on this line occurred at a weighted average price of $301.61 (range $301.09 to $302.01).
- Open market sales reported on this line occurred at a weighted average price of $302.55 (range $302.13 to $302.90).
- Open market sales reported on this line occurred at a weighted average price of $303.78 (range $303.13 to $304.09).
- Open market sales reported on this line occurred at a weighted average price of $304.67 (range $304.13 to $305.12).
- Open market sales reported on this line occurred at a weighted average price of $305.38 (range $305.13 to $305.83).
- Fully vested.
Billionaire Hedge Funds
